We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOW icon
26
ServiceNow
NOW
$102B
$131M 0.66%
857,541
+24,161
+3% +$4.14M
AMGN icon
27
Amgen
AMGN
$203B
$128M 0.64%
391,735
-53,485
-12% -$17M
ABT icon
28
Abbott
ABT
$180B
$128M 0.64%
1,018,815
-153,545
-13% -$19.6M
A icon
29
Agilent Technologies
A
$39.1B
$124M 0.62%
913,083
+30,853
+3% +$4.43M
TSLA icon
30
Tesla
TSLA
$1.24T
$118M 0.59%
262,789
-35,471
-12% -$15.7M
BSX icon
31
Boston Scientific
BSX
$65.8B
$108M 0.54%
1,129,838
-117,633
-9% -$11.5M
DHR icon
32
Danaher
DHR
$135B
$108M 0.54%
469,770
+24,914
+6% +$5.48M
WM icon
33
Waste Management
WM
$95.9B
$105M 0.52%
478,970
-102,472
-18% -$21.8M
XYL icon
34
Xylem
XYL
$28.5B
$104M 0.52%
761,423
+205,821
+37% +$29.6M
BKNG icon
35
Booking.com
BKNG
$138B
$103M 0.52%
482,775
+51,350
+12% +$10.6M
AMD icon
36
Advanced Micro Devices
AMD
$851B
$103M 0.51%
481,068
-1,003
-0.2% -$225K
AXP icon
37
American Express
AXP
$223B
$102M 0.51%
277,052
+34,140
+14% +$12.2M
VRTX icon
38
Vertex Pharmaceuticals
VRTX
$121B
$102M 0.51%
225,292
+50,725
+29% +$21.9M
IQV icon
39
IQVIA
IQV
$34.7B
$101M 0.5%
447,319
+174,572
+64% +$38M
HD icon
40
Home Depot
HD
$332B
$101M 0.5%
292,907
-44,946
-13% -$16.5M
SPGI icon
41
S&P Global
SPGI
$126B
$97.1M 0.48%
185,706
+61,047
+49% +$30.2M
PG icon
42
Procter & Gamble
PG
$343B
$96M 0.48%
669,508
-231,200
-26% -$34.1M
WAB icon
43
Wabtec
WAB
$51.1B
$95.4M 0.48%
447,018
-35,968
-7% -$7.39M
NU icon
44
Nu Holdings
NU
$68.1B
$95.4M 0.48%
5,695,700
+825,700
+17% +$13.3M
NEE icon
45
NextEra Energy
NEE
$187B
$95.2M 0.47%
1,185,804
+493,635
+71% +$40.9M
ALNY icon
46
Alnylam Pharmaceuticals
ALNY
$36.3B
$89.2M 0.44%
224,330
+11,914
+6% +$5.27M
MPWR icon
47
Monolithic Power Systems
MPWR
$65.5B
$85.6M 0.43%
94,447
+8,540
+10% +$8.22M
ADI icon
48
Analog Devices
ADI
$181B
$84.3M 0.42%
310,902
+50,178
+19% +$12.6M
ON icon
49
ON Semiconductor
ON
$33.8B
$82.4M 0.41%
1,521,320
-90,659
-6% -$4.65M
ICE icon
50
Intercontinental Exchange
ICE
$82.4B
$82.3M 0.41%
507,864
-167,416
-25% -$26.2M

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.